Latest data shows the largest indicative borrow rate increases among liquid option names include: BHP Billiton (BHP) 14.94% +4.96, Bitfarms ...
Lexicon Pharmaceuticals (NASDAQ:LXRX) is scheduled to announce Q4 earnings results on Thursday, March 6th, after market close. The consensus EPS Estimate is -$0.12 (+40.0% Y/Y) and the consensus ...
21h
Fintel on MSNLeerink Partners Downgrades Lexicon Pharmaceuticals (LXRX)Fintel reports that on March 4, 2025, Leerink Partners downgraded their outlook for Lexicon Pharmaceuticals (NasdaqGS:LXRX) ...
Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at HC Wainwright in a report issued on Monday,Benzinga reports. They ...
Needham analyst Joseph Stringer maintained a Hold rating on Lexicon Pharmaceuticals (LXRX – Research Report) today. The company’s shares opened ...
Lexicon Pharmaceuticals shares are trading lower by 48% Monday morning. The company earlier announced topline results from ...
Shares of Lexicon Pharmaceuticals , Inc. (Nasdaq: NASDAQ: LXRX) plummeted 50% following the announcement of topline results from its Phase 2b PROGRESS study, which evaluated the efficacy of ...
Investing.com -- Shares of Lexicon Pharmaceuticals , Inc. (NASDAQ: LXRX) tumbled 55% after the company announced topline results from its PROGRESS Phase 2b study, which evaluated pilavapadin in ...
Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday ...
Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results